bioRxivCancer BiologyPreprint
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer
Audrey M. HendleyiD, Sudipta AsheiD, Atsushi Urano, Martin Ng, Tuan Anh PhuiD, Xianlu L. PengiD, Changfei Luan, Anna‐Marie FingeriD, Gun Ho JangiD, Natanya R. Kerper, David I. BerriosiD, David S. JiniD, Jonghyun LeeiD, Irene Riahi, Oghenekevwe M. GbenedioiD, Christina Chung, Jeroen P. RooseiD, Jen Jen YehiD, Steve GallingeriD, Andrew Victor BiankiniD, Grainne Mary O'KaneiD, Vasilis NtranosiD, David Kuang-Fu ChangiD, David W. DawsoniD, Grace E. Kim, , Matthias HebrokiD
Abstract
The pleiotropic roles of nSMase2-generated ceramide include regulation of intracellular ceramide signaling and exosome biogenesis. We investigated the effects of eliminating nSMase2 on early and advanced PDA, including its influence on the microenvironment. Employing the KPC mouse model of pancreatic cancer, we demonstrate that pancreatic epithelial nSMase2 ablation reduces neoplasia and promotes a PDA subtype switch from aggressive basal-like to classical. nSMase2 elimination prolongs survival of KPC mice, hinders vasculature development, and fosters a robust immune response. nSMase2 loss leads to recruitment of cytotoxic T cells, N1-like neutrophils, and abundant infiltration of anti-tumorigenic macrophages in the pancreatic preneoplastic microenvironment. Mechanistically, we demonstrate that nSMase2-expressing PDA cell small extracellular vesicles (sEVs) reduce survival of KPC mice; PDA cell sEVs generated independently of nSMase2 prolong survival of KPC mice and reprogram macrophages to a proinflammatory phenotype. Collectively, our study highlights previously unappreciated opposing roles for exosomes, based on biogenesis pathway, during PDA progression. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=189 SRC="FIGDIR/small/614610v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@b6e6d1org.highwire.dtl.DTLVardef@1ebb41eorg.highwire.dtl.DTLVardef@17e4275org.highwire.dtl.DTLVardef@3d31f1_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Silencing the signal: The metastasis suppressor NDRG1 disrupts exosome-mediated crosstalk in pancreatic cancer
Jiawei Chang, Shafi Alenizi, … Žaklina Kovačević·bioRxiv·Oct 15, 2025
- Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer
Chiara Falcomatà, Sebastian Rune Nielsen, … Brian D. Brown·bioRxiv·Jun 11, 2025
- Sympathetic axonal sprouting induces changes in macrophage populations and protects against pancreatic cancer
J. Guillot, C. Dominici, … F. Mann·bioRxiv·Apr 27, 2020
- Pancreatic Tumor-Derived Extracellular Vesicles Stimulate Schwann Cell Phenotype Indicative of Perineural Invasion via IL-8 Signaling
E. Gregory, I. Powers, … Y. Song·bioRxiv·Jun 26, 2023
- The basal cell state maintains pancreatic cancers by controlling an immunosuppressive circuit
Anupriya Singhal, Kate Ryan, … Tuomas Tammela·bioRxiv·Jul 14, 2026
- VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment.
T. Passang, S. Wang, … E. K. Waller·bioRxiv·Jan 16, 2024